@joraltron.bsky.social
Reposted
Predictors of response to intravenous #immunoglobulin in patients with #dermatomyositis: the ProDERM study
💉IVIg was effective regardless of demographic features and #autoantibody status.
💉Higher cutaneous activity and/or #anti-TIF1-γ responded better
academic.oup.com/rheumatology...
💉IVIg was effective regardless of demographic features and #autoantibody status.
💉Higher cutaneous activity and/or #anti-TIF1-γ responded better
academic.oup.com/rheumatology...
Predictors of response to intravenous immunoglobulin in patients with dermatomyositis: the ProDERM study
AbstractObjectives. The phase 3 ProDERM study demonstrated intravenous immunoglobulin (IVIg) was safe and effective in patients with dermatomyositis (DM).
academic.oup.com
February 23, 2025 at 11:09 AM
Predictors of response to intravenous #immunoglobulin in patients with #dermatomyositis: the ProDERM study
💉IVIg was effective regardless of demographic features and #autoantibody status.
💉Higher cutaneous activity and/or #anti-TIF1-γ responded better
academic.oup.com/rheumatology...
💉IVIg was effective regardless of demographic features and #autoantibody status.
💉Higher cutaneous activity and/or #anti-TIF1-γ responded better
academic.oup.com/rheumatology...
